Company news

Cynata Therapeutics Limited news in 2016

Cynata Therapeutics Limited's news releases, calls and decks from 2016, newest first.

View company

Cynatas Clinical Study Approved in Austrralia

December 15, 2016

Cynata Receives NHS HRA Approval for Clinical Study

December 12, 2016

Cynata Files Further Patent Application

November 28, 2016

Cynata Receives $1.749m R&D Tax Incentive Refund

November 15, 2016

Activities Report & Appendix 4C

October 31, 2016

Efficacy for CYP MSC Technology in Preclinical Asthma Study

October 16, 2016

UK Regulatory Authority Approves Cynata GvHD Clinical Trial

September 19, 2016

CYP Determines not to proceed with Regience Investment Offer

September 5, 2016

CYP & FUJIFILM Sign Non-Binding Terms Sheet

September 4, 2016

Cynata Files Application to Commence Phase 1 Clinical Trial

July 31, 2016

Cynata Receives Investment Offer from Regience

June 30, 2016

Cynata Prepares for Phase 1 Clinical Trial

June 20, 2016

Cynata Enters Agreement with apceth GmbH & Co KG

May 8, 2016

CYP Manufactures CT Product-Files Further Patent Application

May 5, 2016

Decision to Grant Patent for Cymerus MSC Technology in Japan

May 2, 2016

Cynata & Regience Extend Entitlement Period

April 29, 2016

Compelling Results from Pre-Clinical Stem Cell Study in GvHD

April 6, 2016

Cynata Announces Landmark Licensing Deal

March 30, 2016

Cynata Enters Agreement for Strategic Alliance in Japan

March 3, 2016

Cynata Receives $930k R&D Tax Incentive Refund

February 15, 2016

Quarterly Activities Report & Appendix 4C

February 11, 2016

CYP Receives Favourable Advice from UK Regulatory Authority

February 10, 2016

Decks in 2016